Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heide L Ford

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
Biochimica Et Biophysica Acta. Reviews on Cancer|March 30, 2024
All eyes on Eya: A unique transcriptional co-activator and phosphatase in cancerConnor J Hughes, Christopher Alderman, Arthur R Wolin, et al.
Nature Structural & Molecular Biology|February 26, 2013
Structure-function analyses of the human SIX1-EYA2 complex reveal insights into metastasis and BOR syndromeAaron N Patrick, Joshua H Cabrera, Anna L Smith, et al.
Molecular Pharmacology|December 16, 2016
Non-cell-autonomous Effects of Autophagy Inhibition in Tumor Cells Promote Growth of Drug-resistant CellsJacqueline Thorburn, Leah Staskiewicz, Megan L Goodall, et al.
Cancer Research|April 3, 2008
Six1 overexpression in mammary cells induces genomic instability and is sufficient for malignant transformationRicardo D Coletta, Kimberly L Christensen, Douglas S Micalizzi, et al.
Cancer Research|April 6, 2007
Six1 overexpression in ovarian carcinoma causes resistance to TRAIL-mediated apoptosis and is associated with poor survivalKian Behbakht, Lubna Qamar, Carrie S Aldridge, et al.
Cell Cycle (Georgetown, Tex.)|November 8, 2013
CDK6 binds and promotes the degradation of the EYA2 proteinDawn Kohrt, Jennifer Crary, Marc Zimmer, et al.
BMC Developmental Biology|January 16, 2010
Characterization of the Six1 homeobox gene in normal mammary gland morphogenesisRicardo D Coletta, Erica L McCoy, Valerie Burns, et al.
Oncogene|December 10, 2020
VEGF-C mediates tumor growth and metastasis through promoting EMT-epithelial breast cancer cell crosstalkDeguang Kong, Hengbo Zhou, Deepika Neelakantan, et al.
Chemmedchem|June 11, 2024
Rational Design of Novel Allosteric EYA2 Inhibitors as Potential Therapeutics for Multiple Brain CancersLukas Gardner, John Rossi, Brock Armstrong, et al.
Nature Communications|March 15, 2018
Eya3 partners with PP2A to induce c-Myc stabilization and tumor progressionLingdi Zhang, Hengbo Zhou, Xueni Li, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Biochimica Et Biophysica Acta. Reviews on Cancer|March 30, 2024
All eyes on Eya: A unique transcriptional co-activator and phosphatase in cancerConnor J Hughes, Christopher Alderman, Arthur R Wolin, et al.
Nature Structural & Molecular Biology|February 26, 2013
Structure-function analyses of the human SIX1-EYA2 complex reveal insights into metastasis and BOR syndromeAaron N Patrick, Joshua H Cabrera, Anna L Smith, et al.
Molecular Pharmacology|December 16, 2016
Non-cell-autonomous Effects of Autophagy Inhibition in Tumor Cells Promote Growth of Drug-resistant CellsJacqueline Thorburn, Leah Staskiewicz, Megan L Goodall, et al.
Cancer Research|April 3, 2008
Six1 overexpression in mammary cells induces genomic instability and is sufficient for malignant transformationRicardo D Coletta, Kimberly L Christensen, Douglas S Micalizzi, et al.
Cancer Research|April 6, 2007
Six1 overexpression in ovarian carcinoma causes resistance to TRAIL-mediated apoptosis and is associated with poor survivalKian Behbakht, Lubna Qamar, Carrie S Aldridge, et al.
Cell Cycle (Georgetown, Tex.)|November 8, 2013
CDK6 binds and promotes the degradation of the EYA2 proteinDawn Kohrt, Jennifer Crary, Marc Zimmer, et al.
BMC Developmental Biology|January 16, 2010
Characterization of the Six1 homeobox gene in normal mammary gland morphogenesisRicardo D Coletta, Erica L McCoy, Valerie Burns, et al.
Oncogene|December 10, 2020
VEGF-C mediates tumor growth and metastasis through promoting EMT-epithelial breast cancer cell crosstalkDeguang Kong, Hengbo Zhou, Deepika Neelakantan, et al.
Chemmedchem|June 11, 2024
Rational Design of Novel Allosteric EYA2 Inhibitors as Potential Therapeutics for Multiple Brain CancersLukas Gardner, John Rossi, Brock Armstrong, et al.
Nature Communications|March 15, 2018
Eya3 partners with PP2A to induce c-Myc stabilization and tumor progressionLingdi Zhang, Hengbo Zhou, Xueni Li, et al.
Pageof 9